Herzer P - Search Results

1

Infections in patients with rheumatoid arthritis treated with biologic agents.

Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, Kekow J, Schneider M, Zink A. Listing J, et al. Among authors: herzer p. Arthritis Rheum. 2005 Nov;52(11):3403-12. doi: 10.1002/art.21386. Arthritis Rheum. 2005. PMID: 16255017

2

Sustainability of rituximab therapy in different treatment strategies: results of a 3-year followup of a German biologics register.

Richter A, Strangfeld A, Herzer P, Wilden E, Bussmann A, Listing J, Zink A. Richter A, et al. Among authors: herzer p. Arthritis Care Res (Hoboken). 2014 Nov;66(11):1627-33. doi: 10.1002/acr.22327. Arthritis Care Res (Hoboken). 2014. PMID: 24664818 Free PMC article.

3

Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.

Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A. Strangfeld A, et al. Among authors: herzer p. JAMA. 2009 Feb 18;301(7):737-44. doi: 10.1001/jama.2009.146. JAMA. 2009. PMID: 19224750

4

Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials.

Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F, Stoyanova-Scholz M, Wassenberg S, Kapelle A, Listing J. Zink A, et al. Among authors: herzer p. Arthritis Rheum. 2006 Nov;54(11):3399-407. doi: 10.1002/art.22193. Arthritis Rheum. 2006. PMID: 17075823

5

Treatment continuation in patients receiving biological agents or conventional DMARD therapy.

Zink A, Listing J, Kary S, Ramlau P, Stoyanova-Scholz M, Babinsky K, von Hinueber U, Gromnica-Ihle E, Wassenberg S, Antoni C, Herzer P, Kekow J, Schneider M, Rau R. Zink A, et al. Among authors: herzer p. Ann Rheum Dis. 2005 Sep;64(9):1274-9. doi: 10.1136/ard.2004.031476. Epub 2005 Feb 11. Ann Rheum Dis. 2005. PMID: 15708884 Free PMC article.

6

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs.

Strangfeld A, Richter A, Siegmund B, Herzer P, Rockwitz K, Demary W, Aringer M, Meißner Y, Zink A, Listing J. Strangfeld A, et al. Among authors: herzer p. Ann Rheum Dis. 2017 Mar;76(3):504-510. doi: 10.1136/annrheumdis-2016-209773. Epub 2016 Jul 12. Ann Rheum Dis. 2017. PMID: 27405509 Free PMC article.

7

Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.

Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P. Brenner M, et al. Among authors: herzer p. Br J Dermatol. 2009 Nov;161(5):1199-201. doi: 10.1111/j.1365-2133.2009.09404.x. Epub 2009 Aug 10. Br J Dermatol. 2009. PMID: 19673875

8

Lyme arthritis in Europe: comparisons with reports from North America.

Herzer P. Herzer P. Ann Rheum Dis. 1988 Sep;47(9):789-90. doi: 10.1136/ard.47.9.789. Ann Rheum Dis. 1988. PMID: 3178319 Free PMC article. No abstract available.

9

Ultrasound findings in Löfgren's syndrome: is ankle swelling caused by arthritis, tenosynovitis or periarthritis?

Kellner H, Späthling S, Herzer P. Kellner H, et al. Among authors: herzer p. J Rheumatol. 1992 Jan;19(1):38-41. J Rheumatol. 1992. PMID: 1556697

10

Seronegative spondylarthropathies in HIV-infected patients: further evidence of uncommon clinical features.

Kellner H, Füessl HS, Herzer P. Kellner H, et al. Among authors: herzer p. Rheumatol Int. 1994;13(5):211-3. doi: 10.1007/BF00390270. Rheumatol Int. 1994. PMID: 8202665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results